A report suggested how the HDAC inhibitor LAQ824 includes a higher antitumor activity in conjunction with 13- em cis /em -retinoic acidity in melanoma tumors[24]

A report suggested how the HDAC inhibitor LAQ824 includes a higher antitumor activity in conjunction with 13- em cis /em -retinoic acidity in melanoma tumors[24]

A report suggested how the HDAC inhibitor LAQ824 includes a higher antitumor activity in conjunction with 13- em cis /em -retinoic acidity in melanoma tumors[24]. promyelocytic leukemia. ATRA changes the PML-RAR- fusion proteins into activator of transcription and restores cell differentiation[8]. Retinoids are also looked